BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,126,000 | -22.3% | 136,000 | -9.3% | 1.59% | +15.4% |
| Q4 2021 | $20,741,000 | +10.6% | 150,000 | +11.1% | 1.38% | +4.8% |
| Q3 2021 | $18,753,000 | -3.6% | 135,000 | -32.6% | 1.32% | -0.4% |
| Q2 2021 | $19,457,000 | +42.0% | 200,419 | 0.0% | 1.32% | +38.3% |
| Q1 2021 | $13,699,000 | -32.0% | 200,419 | -14.7% | 0.96% | -41.9% |
| Q4 2020 | $20,142,000 | -0.1% | 235,000 | -24.2% | 1.64% | -8.3% |
| Q3 2020 | $20,153,000 | +31.3% | 310,000 | +47.6% | 1.79% | +8.0% |
| Q2 2020 | $15,353,000 | +222.3% | 210,000 | +50.0% | 1.66% | +148.7% |
| Q1 2020 | $4,764,000 | -30.0% | 140,000 | +12.0% | 0.67% | -10.6% |
| Q4 2019 | $6,805,000 | – | 125,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |